ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the Hot Growth Stocks to Invest in Now. On October 13, Etzer Darout from Barclays initiated ABIVAX Société Anonyme (NASDAQ:ABVX) with an Overweight ...
Recent discussions on X about Abivax (ABVX) have been electrified by the company's announcement of positive Phase 3 trial results for its ulcerative colitis drug, Obefazimod. Many users are ...
Abivax to Present Data on Obefazimod at Digestive Disease Week® Presentations Highlight Comprehensive Efficacy, Safety, and Patient-Reported Outcomes from the Phase 3 ABTECT Program and Preclinical ...
Michigan-based investment advisor Cedar Grove Capital Management recently released its first quarter 2026 investor letter. A ...
Investors with a lot of money to spend have taken a bearish stance on Abivax (NASDAQ:ABVX). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
Investors with a lot of money to spend have taken a bearish stance on Abivax (NASDAQ:ABVX). And retail traders should know. We noticed this today when the positions showed up on publicly available ...
(RTTNews) - Shares of Abivax SA (ABVX) are trading at an all-time high of $80, thanks to the recently announced encouraging clinical trial results for its experimental ulcerative colitis drug, ...
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the 7 Best Strong Buy European Stocks to Invest In. On April 2, 2026, ABIVAX Société Anonyme (NASDAQ:ABVX) appointed Michael Nesrallah as chief ...
ABIVAX Société Anonyme (NASDAQ:ABVX) is one of the hottest large-cap stocks of 2025. On December 16, Piper Sandler raised the firm’s price target on Abivax to $142 from $112, while maintaining an ...
Abivax SA Sponsored ADR (ABVX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results